EN DE
STOCK COMPARISON

Danaher vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Danaher (DHR) and Thermo Fisher Scientific (TMO) compare, as of Nov 5, 2026.

As of Nov 5, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Danaher trades at $226 versus a fair value of $209 (−7.6%), while Thermo Fisher Scientific trades at $677 versus $686 (+1.3%).
Danaher
DHR · USD · Health Care
−7.6%
upside to fair value
fairly valued
Price$226
Fair Value$209
Quality74/100
Fair ValueQualityUptrend
Thermo Fisher Scientific
TMO · USD · Health Care
+1.3%
upside to fair value
fairly valued
Price$677
Fair Value$686
Quality64/100
Fair ValueQualityUptrend
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

DanaherThermo Fisher Scientific
Valuation
37.5×P/E (TTM)35.7×
38.9×P/E ex one-offs (FY2025)37.0×
24.3×Forward P/E (FY2027)24.4×
n/aMedian P/E at FY-end (10 FY, ex one-offs where documented)31.6×
6.25×P/S (TTM)5.30×
3.05× · book value is mostly goodwillP/B4.70× · book value is mostly goodwill
21.1×EV/EBITDA22.7×
1.33×PEG2.03×
−7.6%Fair value upside+1.3%
0.7%Dividend yield0.1%
$1.52Dividend per share$0.43
Profitability
21.1%Operating margin20.2%
1.08×EBIT margin trend (5Y)0.74×
8.2%Return on equity13.4%
4.3%Return on assets6.1%
Growth
8.3%Revenue growth (YoY)9.1%
n/aAvg. growth/yr (3Y)-0.3%
n/aAvg. growth/yr (5Y)6.7%
+5.9%Value creation/yr+2.4%
Balance & size
19.4×Interest coverage (EBIT/interest)5.7×
0.35×Debt / equity0.67×
$160BMarket cap$251B
healthyGrowth qualityhealthy
The P/E excluding one-off items is only shown where the special items are documented in the accounts (our own raw data or SEC filings). If one side lacks it, the reported P/E stays scored.
Thermo Fisher Scientific, median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 6 of the years ex one-offs: 31.6.
Forward P/E: price divided by the analyst consensus for the first fiscal year that has not started yet. The current year carries special items from quarters already reported.

Danaher leads: 8 to 4 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Danaher Thermo Fisher Scientific
ProfitabilityHow much profit the company makes from its sales and capital
37
43
Quality GrowthAre margins and returns getting better?
41
31
CashflowDo the profits arrive as real cash?
85
62
Financial strengthDebt, balance sheet and risk of trouble
79
60
InvestmentDoes it invest with discipline instead of growing at any price?
92
79
Low VolatilityHow calm the share price moves, does not count
71
69
Price momentumPrice momentum of the last 3 to 12 months, does not count
58
71
Near the 52-week highDistance to the 52-week high, does not count
61
72
New sharesBuys back shares or issues new ones?
92
97

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyDanaherPrice $226Thermo Fisher ScientificPrice $677
DCF Models−46.6%below the price$121−38.9%below the price$414
Earnings-Based−77.0%below the price$52.16−69.9%below the price$204
Dividend Discount−89.9%below the price$22.83−95.1%below the price$33.08
Multiples−53.8%below the price$105−54.2%below the price$310
Growth DCF−44.3%below the price$126−46.4%below the price$363
Economic Profit−74.0%below the price$58.81−73.4%below the price$180
Growth Earnings−60.0%below the price$90.57−49.3%below the price$343
Matching families7 of 7
Minimum−89.9%below the price$22.83−95.1%below the price$33.08
Maximum−44.3%below the price$126−38.9%below the price$414
Median−60.0%below the price$90.57−54.2%below the price$310
Geometric mean−68.1%below the price$72.09−68.7%below the price$212
Ahead family by family3 of 74 of 7

Minimum, maximum, median and geometric mean only use the families both stocks have (matching families: 7 of 7), so a family without a value on one side does not distort the comparison. Ahead in a family is the stock whose fair value there sits higher relative to its price. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Family by family: Thermo Fisher Scientific is ahead in 4 of 7 shared families, Danaher in 3.

Danaher: 24 of 24 models see the stock below the current price.

Thermo Fisher Scientific: 24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Danaher
Price $226
Fair Value $209
Bear $137Bull $271
Thermo Fisher Scientific
Price $677
Fair Value $686
Bear $411Bull $892

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Danaher · Health Care

Quality score74 · Top 25%
Fair value upside−7.6% · above median

Thermo Fisher Scientific · Health Care

Quality score64 · Top 25%
Fair value upside+1.3% · above median

Bottom line

As of Nov 5, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Danaher trades at $226 versus a fair value of $209 (−7.6%), while Thermo Fisher Scientific trades at $677 versus $686 (+1.3%).

Danaher has the higher quality score (74/100).

Open Thermo Fisher Scientific live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.